Artículos del autor

solaci

Highlights

New High Blood Pressure Guidelines

The wait is finally over: the high blood pressure guidelines that have been in the works for...
solaci -
Coronary disease

PRESERVE: IV Bicarbonate and Oral N-Acetylcysteine Do Not Prevent Contrast-Associated Acute Kidney Injury

Use of IV bicarbonate instead of saline and administration of oral N-acetylcysteine are not effective strategies for...
solaci -
Acute coronary syndromes

NCDR ACTION Registry: Anticoagulated Patients with No Higher Risk of Bleeding in Emergency Procedures

Patients with a history of atrial fibrillation treated with warfarin or any of the new direct oral anticoagulants undergoing...
solaci -
Highlights

FOURIER: Evolocumab Found Beneficial for Patients with Peripheral Vascular Disease of Prior MI

Patients with peripheral vascular disease or prior acute myocardial infarction (especially within the first two years after the event)...
solaci -
Chronic Ischemic cardiopathy

TRICS III: Restrictive Transfusion Was Noninferior to Liberal Use in Patients Who Undergo Cardiac Surgery

A large study conducted in 19 countries has found that a policy of restrictive red-cell transfusion during cardiac...
solaci -
Institutional News

SOLACI-SUC Joint Session at the Cardiology Congress in Uruguay

From November 9th to November 11th, Punta del Este received the best cardiologists in Latin America. These...
solaci -
Coronary disease

Study Confirms Lead Shields Protect Cath Lab Staff from Radiation Exposure

The recent publication of several reports on risk of cataract, left sided brain tumors, subclinical atherosclerosis and...
solaci -
Structural heart disease

Here you will find the last news about TAVR

1) New Study Confirms TAVR Durability at 5 Years The ADVANCE study was designed to evaluate the safety and effectiveness...
solaci -